Part,  Chapter, Paragraph

 1   II,     5.  2.  4|            prevention) and clinical trials have demonstrated the efficacy
 2   II,     5.  2.  6|      Randomized, placebo-controlled trials performed with various hypocholesterolemic
 3   II,     5.  2.  6|         diminished in many of these trials, even if the association
 4   II,     5.  2.  6|     placebo-controlled intervention trials, has shown that a reduction
 5   II,     5.  2.  6|       participants in 14 randomised trials of statins. Lancet 366:
 6   II,     5.  2.  6|             overviews of randomised trials. Lancet 362: 1527-1535.~
 7   II,     5.  2.  7|     Implications of recent clinical trials for the National Cholesterol
 8   II,     5.  3.  6|             recruitment to clinical trials probably account for most
 9   II,     5.  3.  7|            in randomised controlled trials for breast cancer (mammography)
10   II,     5.  3.  7|       biases. Randomised controlled trials are under way in Europe
11   II,     5.  3.  7|     mortality. The results of those trials should be awaited before
12   II,     5.  3.  7|             not included in pivotal trials. It is necessary to follow
13   II,     5.  5.  3|         some weeks). Thus, clinical trials provide tendencies of efficacy
14   II,     5.  5.  3|             a need for intervention trials that reflect every day practice,
15   II,     5.  5.  3|      Advisory Committee on Clinical Trials on New Agents in Multiple
16   II,     5.  8.  6|             late phases of clinical trials. New evidence is being acquired
17   II,     5.  9.  7|        Pharmacoeconomics in Cinical Trials. Philadelphia: Lippincot-Raven
18   II,     5. 11.  2|      systematic reviews of clinical trials relating to skin conditions (www
19   II,     5. 12.  6|        implementation of randomised trials, is advisable. (Schuppan
20   II,     9        |         placebo-controlled clinical trials have shown that beta-blockers,
21   II,     9        |           from secondary prevention trials; in general, therapies that
22   II,     9        |         major lipid-lowering statin trials showed a 29-percent reduction
23   II,     9.  3.  1|           transition.~ ~In clinical trials, mastalgia has been related
24   II,     9.  3.  1|         placebo-controlled clinical trials have shown that beta-blockers,
25   II,     9.  3.  1|           from secondary prevention trials; in general, therapies that
26   II,     9.  3.  1|         major lipid-lowering statin trials showed a 29-percent reduction
27   II,     9.  4.  3|             are not enough specific trials conducted on older patients.
28   II,     9.  4.  3|         patients. Specific clinical trials are needed for elderly women
29   II,     9.  4.  3|            and over are included in trials, but tend to be selected
30   II,     9.  4.  3|          are particularly healthy). Trials conducted specifically for
31   II,     9.  4.  5|            older people in clinical trials would also be of benefit (
32   II,     9.  5.  1|          Most research and clinical trials are made on men, with results
33  III,    10.  2.  1|          community-based prevention trials. Nordic Studies on Alcohol
34  III,    10.  2.  1| methodological analysis of clinical trials of treatments for alcohol
35  III,    10.  2.  1|          2004). Taken together, the trials, which included more than
36  III,    10.  2.  2|         diminished in many of these trials, even if the association
37  III,    10.  4.  1|       particles that, in laboratory trials, show the highest toxicity
38   IV,    11.  4    |        mainly randomised controlled trialsClinical epidemiology
39   IV,    12.  1    |      Setting Standards for clinical trials, marketing, & advertising
40   IV,    12. 10    |           for Somatic Gene-Transfer Trials (Deutsches Register für
41   IV,    13.  6.  2|       ethical challenge of clinical trials where children are concerned.